๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A phase II trial of 4-demethoxydaunorubicin in refractory epithelial ovarian cancer

โœ Scribed by John J. Kavanagh; Larry J. Copeland; David M. Gershenson; Patton B. Saul; Creighton L. Edwards


Book ID
119052585
Publisher
Elsevier Science
Year
1986
Tongue
English
Weight
238 KB
Volume
24
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Oral 4-demethoxydaunorubicin (idarubicin
โœ Howard S. Hochster; Michael D. Green; Ronald H. Blum; James C. Wernz; James L. S ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› Springer US ๐ŸŒ English โš– 258 KB

Eighteen patients with non-small cell lung cancer were entered into a phase II protocol of oral 4-demethoxydaunorubicin. All were evaluable for toxicity and 17 for response. The major toxicity was hematologic with eight patients developing an ECOG grade 3 or 4 toxicity. There were no responses to th